FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan. 9, 2006--Applied Biosystems Group (NYSE:ABI): Applied Biosystems to Serve End-User Clinical Diagnostics Instrumentation Market as well as Research Markets Conference Call at 10 a.m. EST Tomorrow Applera Corporation today announced that its Board of Directors has approved a restructuring of its Celera Diagnostics joint venture, whereby, effective January 1, 2006, Applied Biosystems has transferred its 50 percent interest in the joint venture to Celera Genomics in exchange for a package of considerations to Applied Biosystems. Since its formation in 2001, Celera Diagnostics has been held equally by Applera’s two business groups, Applied Biosystems Group (NYSE:ABI) and Celera Genomics Group (NYSE:CRA).
